- Published on
KembaraXtra-Medicine – Amebiasis
Amebiasis is an infection caused by the protozoal parasite Entamoeba histolytica. Although it primarily involves the colon, the disease may extend beyond the intestine, most notably causing amebic liver abscess, which is the most common and serious extraintestinal manifestation. When the intestinal infection is severe and associated with dysentery, it is also referred to as amebic dysentery. Amebiasis is classified under ICD-10CM codes A06.9 (amebiasis, unspecified), A06.1 (chronic intestinal amebiasis), and A06.7 (cutaneous amebiasis).
From an epidemiologic perspective, the incidence of amebiasis in the United States is approximately 1.2 cases per 100,000 population. Although relatively uncommon, it is clinically significant and occurs most frequently among institutionalized individuals, travelers to or immigrants from developing countries, and individuals engaging in oral–anal sexual practices. The estimated prevalence in the United States is about 4%, with approximately 80% of infections remaining asymptomatic. In contrast, in the developing world, amebiasis continues to be a major cause of morbidity and mortality, accounting for approximately 9% of all deaths in children younger than 5 years of age. The disease affects males and females equally overall; however, there is a marked male predominance in cases of amebic liver abscess. Amebiasis most commonly affects individuals in the second through sixth decades of life, with peak incidence noted in children aged 2 to 3 years and in adults older than 40 years.
The clinical presentation of amebiasis is often nonspecific, and many infected individuals remain asymptomatic. Approximately 20% of patients develop symptoms, most commonly diarrhea, which may be bloody, along with abdominal or back pain. In severe intestinal disease, abdominal tenderness is present in about 83% of cases, and fever occurs in approximately 38%. Patients with amebic liver abscess typically present with hepatomegaly, right upper quadrant abdominal tenderness, and fever, although these findings may be absent in fulminant disease.
The etiology of amebiasis involves infection with E. histolytica, while E. dispar and E. moshkovskii are more common but nonpathogenic species that are morphologically indistinguishable from E. histolytica. Transmission occurs through the fecal–oral route, and infection is highly contagious, requiring ingestion of only a small number of cysts in contaminated food or water. The infection is usually localized to the large intestine, particularly the cecum, where it may form a localized inflammatory mass known as an ameboma. In some cases, the organism invades the intestinal mucosa and gains access to the portal circulation, leading to extraintestinal disease. Important risk factors include travel to endemic regions, residence in institutions for the intellectually disabled, immunodeficiency, and male sex, particularly with respect to liver abscess formation.
The differential diagnosis of severe intestinal amebiasis includes ulcerative colitis and other forms of infectious enterocolitis, such as those caused by Shigella, Salmonella, Campylobacter, or invasive Escherichia coli. In elderly patients, ischemic colitis may present with a similar clinical picture and should also be considered.
The diagnostic workup focuses on stool-based testing and evaluation for extraintestinal disease. Stool antigen testing is more sensitive than routine ova and parasite examination for diagnosing amebiasis. Examination of three stool specimens collected over 7 to 10 days yields a sensitivity of 85% to 95%, although microscopy cannot reliably distinguish pathogenic from nonpathogenic species. Diagnostic yield can be improved by concentrating and staining specimens with Lugol iodine or methylene blue, and fecal leukocytes may or may not be present.
Laboratory testing includes fecal enzyme-linked immunosorbent assay (ELISA) antigen detection, which is specific for E. histolytica and has a sensitivity of approximately 87% and specificity greater than 90%. Polymerase chain reaction (PCR) assays on stool samples provide 90% to 95% sensitivity and 95% to 100% specificity. In selected cases, mucosal biopsy may be required to identify cysts or trophozoites. Serologic antibody tests are particularly useful in diagnosing extraintestinal disease, including liver abscess, although they may not distinguish recent from remote infection. Aspiration of abscess fluid is sometimes necessary to differentiate amebic from bacterial liver abscesses.
Imaging studies, including abdominal ultrasound or CT scanning, are essential for diagnosing amebic liver abscess and assessing its size, location, and potential complications.
Treatment is required for all patients infected with E. histolytica, regardless of symptom severity. Nonpathogenic Entamoeba species do not require therapy. Management of invasive disease typically begins with tinidazole, which is preferred for initial parasitic clearance, followed by an intraluminal amebicide such as paromomycin or diloxanide furoate to eradicate intestinal cysts. Metronidazole is an acceptable alternative to tinidazole for both intestinal disease and liver abscess. Amebic liver abscess generally responds well to medical therapy, but surgical intervention may be necessary in cases of toxic megacolon, impending rupture, or extension of the abscess into adjacent structures, including the pericardium.
Regarding disposition, host immunity after infection is incomplete, and reinfection rates are high in individuals who remain at risk. Referral to an infectious diseases specialist is recommended for patients with extraintestinal disease, persistent infection, or relapse. Surgical consultation is indicated for patients with toxic megacolon or complicated liver abscesses.
Important clinical considerations include the frequent coexistence of other intestinal parasites, particularly Giardia lamblia, and the high prevalence of nonpathogenic E. dispar colonization among homosexual men, which can complicate diagnosis. In the United States, E. histolytica remains the third most commonly isolated pathogen in returning travelers with infectious gastroenteritis, underscoring the importance of maintaining a high index of suspicion in appropriate clinical settings.
0 Comments
